Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × pixantrone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lymphoma, Non-Hodgkin 6 Recurrence 3 Lymphoma, Follicular 3 Lymphoma, Large B-Cell, Diffuse 2 Neoplasm Metastasis 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

pembrolizumab 135 Gemcitabine 122 Capecitabine 114 Fluorouracil 106 Paclitaxel 105 Oxaliplatin 96 Bevacizumab 95 Nivolumab 92 Leucovorin 89 Docetaxel 84 Radiosurgery 83 Irinotecan 78 Cisplatin 75 Carboplatin 75 Magnetic Resonance Spectroscopy 65 Cyclophosphamide 62 Cetuximab 62 Specimen Handling 56 Biopsy 56 Radiotherapy 52 Trastuzumab 51 Ipilimumab 45 Drug Therapy 45 Everolimus 41 Albumin-Bound Paclitaxel 40 Pemetrexed 39 130-nm albumin-bound paclitaxel 39 Fulvestrant 36 Doxorubicin 36 aldesleukin 35

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01632436 2023-10-02

Hepatic

CTI BioPharma

Phase 1 Withdrawn

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡